This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Prognosis of CML

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Median survival is 4-6 years (can range from less than 1 year to more than 10 years)

  • however occasionally patients die within a few months
  • 3% of patients live more than 15 years without radical therapy
  • once the accelerated phase is reached survival is usually less than 1 year and in the blast phase, few patients survive more than a few months (1).

It is important to identify the prognostic factors at diagnosis. The following can be used to provide useful prognostic information in a patient with CML:

  • accurate identification of the disease stage (or phase) is considered to be the essential factor
  • clinical and laboratory features - used to calculate prognostic scores (Sokal score or Hasford score)
    • these scores identifies patients with low, intermediate, and high risk of short term survival
  • cytogenetic changes e.g. - deletions of the derivative chromosome 9
    • Imatinib can be used to partly overcome the negative prognostic effects of this
    • but the size and location of the deletion appears to be important
  • degree and timing of haematological, cytogenetic, and molecular responses (2)

Approximately 60% of young adults with successful allogeneic bone marrow transplantation are cured.

Studies have revealed that the following features are predictive of a shorter chronic phase:

  • increased splenomegaly.
  • older age
    • chronic myeloid leukaemia mortality is strongly related to age, with the highest mortality rates being in older people. In the UK in 2014-2016, on average each year two-thirds (66%) of deaths were in people aged 75 and over
  • male gender
  • elevated serum lactate dehydrogenase.
  • cytogenetic abnormalities in addition to the Ph1.
  • a higher proportion of marrow or peripheral blood blasts.
  • basophilia.
  • eosinophilia.
  • thrombocytosis.
  • anaemia (1)

Reference:


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.